• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Endocare

Endocare

Endocan Corp ENDO

Last Price$0.01Day Change (%)22.37%
Open Price$0.01Day Change ($)0.00
Day Range0.01–0.0152-Week Range0.00–0.03

As of Tue 5/24/2016 3:04:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces an Investigation of Claims Against Endo International plc and Advises Investors to Contact the Firm

    IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces an Investigation of Claims Against Endo International plc and Advises Investors to Contact the Firm

  2. Washington, California Sue Johnson & Johnson Over Vaginal Mesh Implants

    Washington, California Sue Johnson & Johnson Over Vaginal Mesh Implants

  3. Endo Cuts Annual Guidance on Impairment Charge

    Endo Cuts Annual Guidance on Impairment Charge

  4. Endo Pharma's stock is on track to log its largest one-day loss in 14 years

    Endo Pharma's stock is on track to log its largest one-day loss in 14 years

  5. UPDATE: The Fed won't raise interest rates if this happens

    UPDATE: The Fed won't raise interest rates if this happens

  6. UPDATE: How investors can profit from 'funny' corporate accounting

    UPDATE: How investors can profit from 'funny' corporate accounting

  7. UPDATE: How investors can profit from 'funny' corporate accounting

    UPDATE: How investors can profit from 'funny' corporate accounting

  8. UPDATE: How investors can profit from 'funny' corporate accounting

    UPDATE: How investors can profit from 'funny' corporate accounting

  9. Technavio Announces Top Six Vendors in the Global Migraine Drugs Market Until 2020

    Technavio Announces Top Six Vendors in the Global Migraine Drugs Market Until 2020

  10. MARKET SNAPSHOT: Stocks End Higher After Jobs Report, But Book 2nd Weekly Decline In A Row

    MARKET SNAPSHOT: Stocks End Higher After Jobs Report, But Book 2nd Weekly Decline In A Row

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.